NuMe Health Raises $675,000 Series A For Prebiotic Disease Prevention and Management

11 years ago

NuMe Health, the New Orleans biotechnology company developing prebiotics for disease prevention, closed its series A-1 financing round and hired Dean P. Stull, PhD, as chief executive officer.  The ...